UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006241
Receipt number R000007336
Scientific Title Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.
Date of disclosure of the study information 2011/08/28
Last modified on 2018/07/17 20:10:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Acronym

Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Scientific Title

Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Scientific Title:Acronym

Analysis of factors and individual differences in clinical efficacy and pharmacokinetics of enoxaparin,fondaparinux.

Region

Japan


Condition

Condition

knee replacement surgery

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysis of factors could explain the adverse effects of individual differences in the treatment of fondaparinux and enoxaparin anticoagulant,further to examine the usefulness of coagulation markers for the diagnosis of thrombos.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

effectiveness and relevance of pharmacokinetics and safety.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Fondaparinux

Interventions/Control_2

Enoxaparin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

20 years-old >

Gender

Male and Female

Key inclusion criteria

Patients undergoing knee replacement surgery

Key exclusion criteria

under twenty years.
with a history of DVT and PTE.
With the disease have abnormal clotting.
Patient's written consent not obtained.
contraindications to enoxaparin or fondaparinux.
The patient has been administered warfarin.
Patients with other treating physician deems inappropriate.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasunori Tsukimura

Organization

Kitasato university, Kitasato institute hospital

Division name

orthopedics

Zip code


Address

5-9-1 shirokane minato-ku tokyo japan

TEL

03-3444-6161

Email

tsukky@insti.kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name shibata soichi

Organization

Pharmacy

Division name

Pharmacy

Zip code


Address

5-9-1 shirokane minato-ku tokyo japan

TEL

03-3444-6161

Homepage URL


Email

shibasoh@insti.kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato university, Kitasato institute hospital,department of orthopedics

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 25 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 08 Month 28 Day

Last modified on

2018 Year 07 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007336


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name